CAMP Q1 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$94M+9.6% YoY

Gross Profit

$38M40.7% margin

Operating Income

$2M2.1% margin

Net Income

-$5M-5.1% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$473M

Total Liabilities

$274M

Stockholders' Equity

$199M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$86M	+9.6%
Gross Profit	$38M	$36M	+7.4%
Operating Income	$2M	-$2M	+183.8%
Net Income	-$5M	-$3M	-36.7%

Revenue Segments

Telematics Systems

$78M83%

Software And Subscription Services

$16M17%

Geographic Segments

UNITED STATES

$68M69%

Europe Middle East And Africa

$12M12%

South America

$12M12%

Asia Pacific

$3M3%

CANADA

$3M3%